ZYME (Zymeworks Inc.) Stock Market Reviews

crown

search

Read and share opinions on ZYME (Zymeworks Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

ZYME

Zymeworks Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Zymeworks Inc. (NASDAQ:ZYME) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Nov 9, 2025
Zymeworks Inc. (ZYME) Reports Q3 Loss, Lags Revenue Estimates
Nov 6, 2025
A Look at Zymeworks (ZYME) Valuation After 50% Share Price Rally Over 3 Months
Nov 4, 2025
Zymeworks Inc. (ZYME) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Oct 30, 2025
Zymeworks (ZYME) Upgraded to Strong Buy: Here's What You Should Know
Oct 29, 2025
Zymeworks Announces Participation in Upcoming Investor Conferences
Oct 28, 2025
Zymeworks Presents Initial Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺ at AACR-NCI-EORTC Conference
Oct 23, 2025
How Recent Developments Are Changing The Zymeworks Investment Story
Oct 23, 2025
Wall Street Analysts Believe Zymeworks (ZYME) Could Rally 25.73%: Here's is How to Trade
Oct 16, 2025
Zymeworks to Report Third Quarter 2025 Financial Results and Host Conference Call on November 6, 2025
Oct 16, 2025
Zymeworks Inc. (ZYME) is a Great Momentum Stock: Should You Buy?
Oct 14, 2025
Zymeworks to Present Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺, at AACR-NCI-EORTC International Conference
Oct 13, 2025
Will Zymeworks’ (ZYME) New R&D Leadership Mark a Turning Point in Its Oncology Strategy?
Oct 12, 2025
Zymeworks (ZYME): Evaluating Valuation After New Oncology Leadership and Renewed Pipeline Momentum
Oct 11, 2025
Zymeworks Appoints Dr. Adam Schayowitz as Acting Chief Development Officer
Oct 9, 2025

Reviews